This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SINGAPORE -- Auntminnie.com spoke with ultrahigh-field MRI expert Nicolas Boulant, PhD, of the NeuroSpin research center near Paris, at the International Society for Magnetic Resonance in Medicine (ISMRM) annual meeting. Boulant channeled the classic spaghetti Western movie “The Good, the Bad, and the Ugly” to describe his team’s early clinical experience neuroimaging 20 subjects using ultrahigh field 11.7 tesla MRI – to date, the highest magnetic field MRI used in humans, he said.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
The company, which offers software to help physicians save time and alleviate burnout, will use the funds to expand global availability of its generative AI solutions.
The company, which offers software to help physicians save time and alleviate burnout, will use the funds to expand global availability of its generative AI solutions.
Korea-based Samsung Medison has signed an agreement to acquire French startup and fetal ultrasound AI software developer Sonio. Sonio will remain an independent company headquartered in France, according to Samsung Medison, and will continue its commercial growth independently while its products and services will remain compatible with all ultrasound device makers.
Three clinical issues that may arise with theranostics treatments will require special provisions, including spot imaging, according to insights shared during the 124th annual meeting of the American Roentgen Ray Society (ARRS) in Boston. Theranostics treatments are used with increasing frequency now since the approvals and expansions of Lutathera (lutetium-177 [Lu-177]) DOTATATE, a radiopharmaceutical for neuroendrocrine tumors (NETs) and Pluvicto, Lu-177 PSMA-617, for prostate cancer.
Determining how to reimburse for healthcare artificial intelligence is likely to be a “complex policy challenge,” CEO William T. Thorwarth Jr., MD, wrote May 6.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
A fluoroscopy method incorporating a noncontrast x-ray pulsatility index (XPI) can improve clinical efficiency as a screening or diagnostic test for suspected chronic thromboembolic pulmonary hypertension, according to research presented at the American Roentgen Ray Society (ARRS) annual meeting. In a May 7 online presentation, Matthew Smith, MD, from Vanderbilt University Medical Center in Nashville, TN, described how the fluoroscopic XPI method could be a suitable alternative to pulmonary angi
Integrating MR elastography (MRE) in a routine MRI scanner and combining it with dynamic contrast-enhanced MRI (DCE-MRI) could predict complete pathological response at the end of neoadjuvant chemotherapy in breast cancer patients, according to a presentation at the International Society for Magnetic Resonance in Medicine (ISMRM) annual meeting. Researchers led by Aish Sinha, MBBS, from King’s College London in England demonstrated how combining DCE-MRI with MRE achieved high sensitivity and spe
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
MRI contrast agent developer Polarean is highlighting upcoming poster presentations at the American Thoracic Society’s (ATS) 2024 Respiratory Innovation Summit (RIS) May 17-18 in San Diego. Nearly 18 months after the company's approval of Xenoview (xenon, Xe-129 hyperpolarized) for oral inhalation during MRI, Polarean's research includes 33 presentations from 10 different sites and multiple categories such as asthma, bronchopulmonary dysplasia, COPD, COVID-19, cystic fibrosis, hematopoietic ste
christine.book Wed, 05/08/2024 - 14:33 May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance , significantly improved visualization of focal liver lesions, successfully meeting the primary endpoint in the pivotal Phase 3 study SPARKLE. A summary of significant updates presented during a corporate update presented May 7, “Bringing Orviglance to Patients,” follows: - The Phase 3 study demonstrated strong superiority in visualization
SINGAPORE - Combining brain MRI and CT radiomic features improves prognosis prediction for lung cancer patients with brain metastasis, according to research presented May 8 at the International Society of Magnetic Resonance in Medicine (ISMRM) meeting. A team led by presenter Jyun-Ru Chen, PhD, of National Yang Ming Chiao Tung University in Taipei, Taiwan, found that "imaging characteristics of both primary and secondary (metastatic) tumors are valuable for prognostic prediction in lung cancer w
In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
In a recent interview, Stacy Smith-Foley, M.D., shared her perspective on the shortcomings of the recently issued breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
A new deep learning technology offers 'urgency scores' and AI-generated diagnoses that can be understood by non-experts, allowing for quicker, crucial treatment.
What would patient care be without the vital role nurses play? What about with respect to AI in clinical care? Nurses and clinical coordinators of Aidoc shared their thoughts on the relationship between nursing and AI in hospital care. Nurses play a pivotal role in AI development and in driving AI adoption into clinical workflows. These AI-augmented clinical workflows aid in patient triage and prioritization , decrease treatment times, coordinate medical decision-making and ultimately improve pa
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
If there is one constant in business today, it’s that technology will continue to evolve rapidly. For evidence, look at your workplace and remember how it was just a few years ago. Technology transformation is apart of every major business process, from product manufacturing to administrative functions like HR and finance. But when you think you are caught up, new tech emerges, and your industry is reshaped yet again.
Dr. Cathrine Keller joins Zotec Answers podcast host Mark Isenberg to explore the implications of the new USPSTF recommendations and their significance for patients and healthcare providers.
A new probe enhances the ablation capabilities for a broad spectrum of oncology and epilepsy targets by incorporating advanced laser and cooling technologies to support a variety of ablation sizes and trajectory lengths.
What would patient care be without the vital role nurses play? What about with respect to AI in clinical care? Nurses and clinical coordinators of Aidoc shared their thoughts on the relationship between nursing and AI in hospital care. Nurses play a pivotal role in AI development and in driving AI adoption into clinical workflows. These AI-augmented clinical workflows aid in patient triage and prioritization, decrease treatment times, coordinate medical decision-making and ultimately improve p
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content